Investment Summary |
|
---|---|
Date | 2022-04-26 |
Target | Biofourmis |
Sector | Software |
Investor(s) | General Atlantic |
Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1980 |
PE ASSETS | 73.0B USD |
Size | Mega |
Type | Sector Agnostic |
General Atlantic is a large private equity firm that invests globally in growth-oriented public and private companies. Broad areas of interest include financial services, media and consumer, healthcare, enterprise solutions, communications and electronics, and energy. General Atlantic looks to invest $40 to $400 million in transactions that support growth, expansions, buy-outs, consolidations and build-ups. General Atlantic seeks to make 8 to 12 investments per year with an investment horizon of five to ten years. The Firm's geographic coverage spans North America; Europe; Asia/Pacific; and India. General Atlantic was formed in 1980 and is based in Greenwich, Connecticut.
DEAL STATS | # |
---|---|
Overall | 319 of 343 |
Sector (Software) | 25 of 27 |
Type (Growth Capital) | 124 of 129 |
State (Massachusetts) | 15 of 17 |
Country (United States) | 153 of 163 |
Year (2022) | 13 of 22 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-04-19 |
ThreatLocker
Orlando, Florida, United States ThreatLocker is a global cybersecurity company, providing enterprise-level cybersecurity tools to improve the security of servers and endpoints. ThreatLocker was founded in 2017 and is based in Orlando, Florida. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-05-05 |
Pantherx
Pittsburgh, Pennsylvania, United States Pantherx is a rare disease pharmacy, comprehensively serving patients afflicted with rare and devastating conditions through the delivery of medical breakthroughs, clinical excellence, and access solutions. Pantherx offers a suite of synchronized compliance, logistics, and analytics solutions to help streamline the process of delivering orphan medications and care to people living with complicated rare diseases. Pantherx was founded in 2011 and is based in Pittsburgh, Pennsylvania. |
Buy | - |